Literature DB >> 6452188

Liberation of catecholamines from blood platelets.

A Pletscher.   

Abstract

1 Platelet-rich plasma (PRP) of guinea-pigs with or without reserpine was preincubated either with [(14)C]-5-hydroxytryptamine ([(14)C]-5-HT) plus [(3)H]-dopamine or with [(14)C]-5-HT plus [(3)H]-noradrenaline ([(3)H]-NA). After isolation on two successive dextran gradients the double-labelled platelets were incubated in Tris-buffer in the presence or absence of various drugs. The decrease in radioactivity in the platelets was measured in order to determine the amount of the amine that had been liberated.2 Spontaneous liberation of the labelled amines was more marked in reserpine-treated platelets than in normal ones and somewhat more pronounced for the (3)H-catecholamines than for [(14)C]-5-HT.3 The reserpine-like benzoquinolizine, Ro 4-1284, caused liberation of all three labelled amines in normal but not in reserpine-treated platelets. More [(3)H]-dopamine was liberated than [(14)C]-5-HT and less [(3)H]-NA.4 The arylalkylamines, tyramine and p-chloromethamphetamine (PCMA), liberated all three labelled amines from normal platelets, and [(14)C]-5-HT and [(3)H]-dopamine, but not [(3)H]-NA from reserpine-treated ones. In normal platelets dopamine was reduced to a greater extent than [(14)C]-5-HT and [(3)H]-NA to a smaller extent, whereas in reserpine-treated platelets [(14)C]-5-HT was more markedly diminished than [(3)H]-dopamine.5 The 5-HT uptake inhibitor, imipramine, had little influence on the spontaneous and drug-induced liberation of [(14)C]-5-HT and [(3)H]-dopamine.6 It is concluded that (3)H-catecholamines like [(14)C]-5-HT are mostly localized in the granular pool of platelets; the three drugs tested liberate [(3)H]-dopamine [(3)H]-NA and [(14)C]-5-HT from the granular pool. Ro 4-1284 does not liberate (3)H-catecholamines and [(14)C]-5-HT from extragranular sites whereas tyramine and PCMA also act on the extragranular pool of [(3)H]-dopamine and [(14)C]-5-HT but not [(3)H]-NA.7 The liberation of catecholamines from platelets differs from that of 5-HT in several respects and platelets are only partly comparable to neurones as far as drug-induced liberation of biogenic amines is concerned.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6452188      PMCID: PMC2071507          DOI: 10.1111/j.1476-5381.1981.tb09134.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Two types of 5-hydroxytryptamine release from isolated blood platelets.

Authors:  G Bartholini; A Pletscher
Journal:  Experientia       Date:  1964-07-15

2.  Effects of reserpine and tyramine on release of norepinephrine from synaptosomes.

Authors:  R W Colburn; I J Kopin
Journal:  Biochem Pharmacol       Date:  1972-03-01       Impact factor: 5.858

3.  Effects of benzoquinolizines and ring-substituted aralkylamines on serotonin metabolism.

Authors:  A Pletscher; M Da Prada; W P Burkard; J P Tranzer
Journal:  Adv Pharmacol       Date:  1968

4.  Storage of exogenous monoamines and reserpine in 5-hydroxytryptamine organelles of blood platelets.

Authors:  M D Prada; A Pletscher
Journal:  Eur J Pharmacol       Date:  1969-07       Impact factor: 4.432

5.  Uptake and efflux of 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease.

Authors:  A Barbeau; G Campanella; R F Butterworth; K Yamada
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

6.  In vitro and in vivo functions of thrombin-treated platelets.

Authors:  H J Reimers; R L Kinlough-Rathbone; J P Cazenave; A F Senyi; J Hirsh; M A Packham; J F Mustard
Journal:  Thromb Haemost       Date:  1976-02-29       Impact factor: 5.249

7.  Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices.

Authors:  K Y Ng; T N Chase; I J Kopin
Journal:  Nature       Date:  1970-10-31       Impact factor: 49.962

8.  Uptake, metabolism and release of (3H)-adrenaline by human platelets.

Authors:  G V Born; J B Smith
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with L-DOPA.

Authors:  D J Boullin; R A O'Brien
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

10.  Uptake and liberation of mepacrine in blood platelets.

Authors:  G B Picotti; M Da Prada; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.